The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics
出版年份 2015 全文链接
标题
The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics
作者
关键词
-
出版物
ONCOGENE
Volume 35, Issue 17, Pages 2145-2155
出版商
Springer Nature
发表日期
2015-08-24
DOI
10.1038/onc.2015.310
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells
- (2015) Craig S. Schneider et al. BIOMATERIALS
- Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
- (2015) O. van Tellingen et al. DRUG RESISTANCE UPDATES
- Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling
- (2015) Evan M Cherry et al. Molecular Cancer
- A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme
- (2015) Sang-Soo Kim et al. Nanomedicine-Nanotechnology Biology and Medicine
- Polymeric drug delivery for the treatment of glioblastoma
- (2015) S. D. Wait et al. NEURO-ONCOLOGY
- Advances in Anticancer Immunotoxin Therapy
- (2015) C. Alewine et al. ONCOLOGIST
- Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
- (2015) Mona Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer nanomedicine: from targeted delivery to combination therapy
- (2015) Xiaoyang Xu et al. TRENDS IN MOLECULAR MEDICINE
- Brain-Penetrating Nanoparticles Improve Paclitaxel Efficacy in Malignant Glioma Following Local Administration
- (2014) Elizabeth Nance et al. ACS Nano
- Ultrasound-mediated blood–brain barrier disruption for targeted drug delivery in the central nervous system
- (2014) Muna Aryal et al. ADVANCED DRUG DELIVERY REVIEWS
- Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway
- (2014) Xiaoping Li et al. ANTI-CANCER DRUGS
- AR-Regulated TWEAK-FN14 Pathway Promotes Prostate Cancer Bone Metastasis
- (2014) J. Yin et al. CANCER RESEARCH
- Targeted anticancer therapy: Overexpressed receptors and nanotechnology
- (2014) Mohd Javed Akhtar et al. CLINICA CHIMICA ACTA
- FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasion
- (2014) Timothy G. Whitsett et al. CLINICAL & EXPERIMENTAL METASTASIS
- A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers
- (2014) U. N. Lassen et al. CLINICAL CANCER RESEARCH
- Regulation of Fibroblast Growth Factor-inducible 14 (Fn14) Expression Levels via Ligand-independent Lysosomal Degradation
- (2014) Sujatha Gurunathan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Analysis of Biodistribution of Intracranially Infused Radiolabeled Interleukin-13 Receptor-Targeted Immunotoxin IL-13PE by SPECT/CT in an Orthotopic Mouse Model of Human Glioma
- (2014) A. Suzuki et al. JOURNAL OF NUCLEAR MEDICINE
- The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion
- (2014) Emily Cheng et al. MOLECULAR CANCER RESEARCH
- Development of Human Serine Protease-Based Therapeutics Targeting Fn14 and Identification of Fn14 as a New Target Overexpressed in TNBC
- (2014) H. Zhou et al. MOLECULAR CANCER THERAPEUTICS
- Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier: Potential for targeting experimental brain tumors
- (2014) Roberto Jose Diaz et al. Nanomedicine-Nanotechnology Biology and Medicine
- Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
- (2014) Vladimir P. Torchilin NATURE REVIEWS DRUG DISCOVERY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Targeting adaptive glioblastoma: an overview of proliferation and invasion
- (2014) Q. Xie et al. NEURO-ONCOLOGY
- Intracranial Applications of Magnetic Resonance-guided Focused Ultrasound
- (2014) Nir Lipsman et al. Neurotherapeutics
- Predictive Gene Signature of Response to the Anti-TweakR mAb PDL192 in Patient-Derived Breast Cancer Xenografts
- (2014) Ludmilla de Plater et al. PLoS One
- In vivo radiation response of proneural glioma characterized by protective p53 transcriptional program and proneural-mesenchymal shift
- (2014) J. Halliday et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma
- (2014) B. J. Gill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- TWEAK/Fn14 axis: The current paradigm of tissue injury-inducible function in the midst of complexities
- (2014) Linda C. Burkly SEMINARS IN IMMUNOLOGY
- Modeling Adult Gliomas Using RCAS/t-va Technology
- (2014) Dolores Hambardzumyan et al. Translational Oncology
- Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
- (2014) J. P. Sullivan et al. Cancer Discovery
- TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases
- (2014) Luis M. Blanco-Colio Frontiers in Immunology
- Emerging Insights into Barriers to Effective Brain Tumor Therapeutics
- (2014) Graeme F. Woodworth et al. Frontiers in Oncology
- Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
- (2013) Roy van der Meel et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- The TWEAK-Fn14 system as a potential drug target
- (2013) Harald Wajant BRITISH JOURNAL OF PHARMACOLOGY
- Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
- (2013) Krishna P.L. Bhat et al. CANCER CELL
- Antitumor Activity of a Humanized, Bivalent Immunotoxin Targeting Fn14-Positive Solid Tumors
- (2013) H. Zhou et al. CANCER RESEARCH
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioblastoma cell chemotaxis via Lyn activation
- (2013) Harshil D. Dhruv et al. CARCINOGENESIS
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy
- (2013) V. Chandramohan et al. CLINICAL CANCER RESEARCH
- RG7212 Anti-TWEAK mAb Inhibits Tumor Growth through Inhibition of Tumor Cell Proliferation and Survival Signaling and by Enhancing the Host Antitumor Immune Response
- (2013) X. Yin et al. CLINICAL CANCER RESEARCH
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-TWEAK Monoclonal Antibody in Patients With Rheumatoid Arthritis
- (2013) Nicolas Wisniacki et al. CLINICAL THERAPEUTICS
- Structural Basis and Targeting of the Interaction between Fibroblast Growth Factor-inducible 14 and Tumor Necrosis Factor-like Weak Inducer of Apoptosis
- (2013) Harshil Dhruv et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity
- (2013) Steffen Salzmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Src Homology 3 Domain-containing Guanine Nucleotide Exchange Factor Is Overexpressed in High-grade Gliomas and Promotes Tumor Necrosis Factor-like Weak Inducer of Apoptosis-Fibroblast Growth Factor-inducible 14-induced Cell Migration and Invasion via Tumor Necrosis Factor Receptor-associated Factor 2
- (2013) Shannon P. Fortin Ensign et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Diphtheria toxin-based targeted toxin therapy for brain tumors
- (2013) Yan Michael Li et al. JOURNAL OF NEURO-ONCOLOGY
- Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment
- (2013) Guifa Xi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Nanotherapeutic approaches for brain cancer management
- (2013) Laura Saenz del Burgo et al. Nanomedicine-Nanotechnology Biology and Medicine
- Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma
- (2013) Giovanna M. Bernal et al. Nanomedicine-Nanotechnology Biology and Medicine
- Strategies for advancing cancer nanomedicine
- (2013) Vikash P. Chauhan et al. NATURE MATERIALS
- Development, maintenance and disruption of the blood-brain barrier
- (2013) Birgit Obermeier et al. NATURE MEDICINE
- Current status of local therapy in malignant gliomas — A clinical review of three selected approaches
- (2013) Tareq A Juratli et al. PHARMACOLOGY & THERAPEUTICS
- Functional Expression of TWEAK and the Receptor Fn14 in Human Malignant Ovarian Tumors: Possible Implication for Ovarian Tumor Intervention
- (2013) Liying Gu et al. PLoS One
- TWEAK-Independent Fn14 Self-Association and NF-κB Activation Is Mediated by the C-Terminal Region of the Fn14 Cytoplasmic Domain
- (2013) Sharron A. N. Brown et al. PLoS One
- Reciprocal Activation of Transcription Factors Underlies the Dichotomy between Proliferation and Invasion of Glioma Cells
- (2013) Harshil D. Dhruv et al. PLoS One
- BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 Proteins Are Related to Human Glioma Tumor Grade: Immunohistochemistry and Public Microarray Data Meta-Analysis
- (2013) Vassiliki Pelekanou et al. PLoS One
- Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
- (2013) A. Sottoriva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma
- (2013) J. Zhou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ
- (2013) Kyeung Min Joo et al. Cell Reports
- Tumor-Penetrating Peptides
- (2013) Tambet Teesalu et al. Frontiers in Oncology
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Elevated Expression of Fn14 in Non-Small Cell Lung Cancer Correlates with Activated EGFR and Promotes Tumor Cell Migration and Invasion
- (2012) Timothy G. Whitsett et al. AMERICAN JOURNAL OF PATHOLOGY
- Glioblastoma: Molecular Analysis and Clinical Implications
- (2012) Jason T. Huse et al. Annual Review of Medicine
- Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
- (2012) Che-Ming Jack Hu et al. BIOCHEMICAL PHARMACOLOGY
- Toxin-Based Targeted Therapy for Malignant Brain Tumors
- (2012) Vidyalakshmi Chandramohan et al. Clinical & Developmental Immunology
- ALKBH3 Contributes to Survival and Angiogenesis of Human Urothelial Carcinoma Cells through NADPH Oxidase and Tweak/Fn14/VEGF Signals
- (2012) K. Shimada et al. CLINICAL CANCER RESEARCH
- Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors
- (2012) Vidyalakshmi Chandramohan et al. INTERNATIONAL JOURNAL OF CANCER
- Drug delivery strategies for the treatment of malignant gliomas
- (2012) Daniela Allhenn et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb
- (2012) Debra T. Chao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The TWEAK Receptor Fn14 Is a Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment
- (2012) Hong Zhou et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases; focus on inflammatory bowel diseases
- (2012) Taeko Dohi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Ultrasound-assisted convection-enhanced delivery to the brain in vivo with a novel transducer cannula assembly
- (2012) George K. Lewis et al. JOURNAL OF NEUROSURGERY
- The disturbed blood–brain barrier in human glioblastoma
- (2012) Hartwig Wolburg et al. MOLECULAR ASPECTS OF MEDICINE
- Cdc42 and the Guanine Nucleotide Exchange Factors Ect2 and Trio Mediate Fn14-Induced Migration and Invasion of Glioblastoma Cells
- (2012) S. P. Fortin et al. MOLECULAR CANCER RESEARCH
- Inflammatory Cytokines and Survival Factors from Serum Modulate Tweak-Induced Apoptosis in PC-3 Prostate Cancer Cells
- (2012) Ana Belen Sanz et al. PLoS One
- Cellular Inhibitors of Apoptosis Are Global Regulators of NF- B and MAPK Activation by Members of the TNF Family of Receptors
- (2012) E. Varfolomeev et al. Science Signaling
- A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue
- (2012) E. A. Nance et al. Science Translational Medicine
- A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid
- (2012) J. J. Iliff et al. Science Translational Medicine
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Prognostic Significance of TWEAK Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion
- (2011) Been-Ren Lin et al. ANNALS OF SURGICAL ONCOLOGY
- Nanoparticle Delivery of Cancer Drugs
- (2011) Andrew Z. Wang et al. Annual Review of Medicine
- Glioblastoma: From Molecular Pathology to Targeted Treatment
- (2011) Timothy F. Cloughesy et al. Annual Review of Pathology-Mechanisms of Disease
- Enhanced Intracellular Delivery and Chemotherapy for Glioma Rats by Transferrin-Conjugated Biodegradable Polymersomes Loaded with Doxorubicin
- (2011) Zhiqing Pang et al. BIOCONJUGATE CHEMISTRY
- Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome
- (2011) Mingguo Huang et al. CARCINOGENESIS
- TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses
- (2011) Linda C. Burkly et al. IMMUNOLOGICAL REVIEWS
- Development of an Fn14 agonistic antibody as an anti-tumor agent
- (2011) Jennifer S. Michaelson et al. mAbs
- Development and Characterization of a Potent Immunoconjugate Targeting the Fn14 Receptor on Solid Tumor Cells
- (2011) H. Zhou et al. MOLECULAR CANCER THERAPEUTICS
- Colocalization of Gadolinium-Diethylene Triamine Pentaacetic Acid With High-Molecular-Weight Molecules After Intracerebral Convection-Enhanced Delivery in Humans
- (2011) John H Sampson et al. NEUROSURGERY
- Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
- (2011) L. Agemy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
- (2011) Vikash P. Chauhan et al. Annual Review of Chemical and Biomolecular Engineering
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- EGFRvIII Antibody-Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery and Targeted Therapy of Glioblastoma
- (2010) C. G. Hadjipanayis et al. CANCER RESEARCH
- Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms
- (2010) P. A. Culp et al. CLINICAL CANCER RESEARCH
- Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas
- (2010) Chien-Tsun Kuan et al. INTERNATIONAL JOURNAL OF CANCER
- Full-length, Membrane-anchored TWEAK Can Function as a Juxtacrine Signaling Molecule and Activate the NF-κB Pathway
- (2010) Sharron A. N. Brown et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Soluble and Transmembrane TNF-Like Weak Inducer of Apoptosis Differentially Activate the Classical and Noncanonical NF- B Pathway
- (2010) C. Roos et al. JOURNAL OF IMMUNOLOGY
- Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study
- (2010) Sabine Mueller et al. JOURNAL OF NEURO-ONCOLOGY
- 'Go or Grow': the key to the emergence of invasion in tumour progression?
- (2010) H. Hatzikirou et al. MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA
- Effect of Pazopanib on Tumor Microenvironment and Liposome Delivery
- (2010) T. D. Tailor et al. MOLECULAR CANCER THERAPEUTICS
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
- (2010) S. Kunwar et al. NEURO-ONCOLOGY
- Small-molecule delivery by nanoparticles for anticancer therapy
- (2010) Zhuo (Georgia) Chen TRENDS IN MOLECULAR MEDICINE
- The Pathobiology of Glioma Tumors
- (2009) Candece L. Gladson et al. Annual Review of Pathology-Mechanisms of Disease
- Convection-enhanced delivery of nanocarriers for the treatment of brain tumors
- (2009) Emilie Allard et al. BIOMATERIALS
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
- (2009) Kazuki N. Sugahara et al. CANCER CELL
- Unsupervised Analysis of Transcriptomic Profiles Reveals Six Glioma Subtypes
- (2009) A. Li et al. CANCER RESEARCH
- Poor drug distribution as a possible explanation for the results of the PRECISE trial
- (2009) John H. Sampson et al. JOURNAL OF NEUROSURGERY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Stimulation of Glioma Cell Survival Is Dependent on Akt2 Function
- (2009) S. P. Fortin et al. MOLECULAR CANCER RESEARCH
- Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model
- (2009) A. B. Madhankumar et al. MOLECULAR CANCER THERAPEUTICS
- The transcriptional network for mesenchymal transformation of brain tumours
- (2009) Maria Stella Carro et al. NATURE
- Using gene expression profiling to identify a prognostic molecular spectrum in gliomas
- (2008) Mitsuaki Shirahata et al. CANCER SCIENCE
- The Fibroblast Growth Factor-Inducible 14 Receptor Is Highly Expressed in HER2-Positive Breast Tumors and Regulates Breast Cancer Cell Invasive Capacity
- (2008) A. L. Willis et al. MOLECULAR CANCER RESEARCH
- Targeting IL-13Rα2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin
- (2008) Mitomu Kioi et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
- (2008) Jeffrey A. Winkles NATURE REVIEWS DRUG DISCOVERY
- Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors
- (2008) John H. Sampson et al. NEURO-ONCOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diffusion in Brain Extracellular Space
- (2008) Eva Syková et al. PHYSIOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now